No Evidence of Sexual Risk Compensation in the iPrEx Trial of Daily Oral HIV Preexposure Prophylaxis

2013236 citationsJournal Articlegold Open Access

Authors

Julia L. Marcus · University of California, Berkeley

David V. Glidden · University of California, San Francisco

Kenneth H. Mayer · Beth Israel Deaconess Medical Center

Albert Liu · University of California, San Francisco

Susan Buchbinder · San Francisco Department of Public Health

K. Rivet Amico · University of Connecticut

Vanessa McMahan

Abstract

There was no evidence of sexual risk compensation in iPrEx. Participants believing they were receiving FTC/TDF had more partners prior to initiating drug, suggesting that risk behavior was not a consequence of PrEP use.

Topics & Keywords

HIV/AIDS Research and Interventions LGBTQ Health, Identity, and Policy HIV, Drug Use, Sexual Risk

UN Sustainable Development Goals

Good health and well-being

Publication Details

Published in: PLoS ONE

Volume 8, Issue 12, pp. e81997-e81997

DOI: 10.1371/journal.pone.0081997

Field-Weighted Citation Impact: 14.23